If you are a member of the general public and not a healthcare professional, NOVELTY study investigator or AstraZeneca Medical employee, please CLICK HERE to see information tailored to you.

14th July, 2020

NOVELTY at ATS 2020

Home > News & events > NOVELTY at ATS 2020

Following cancellation of the physical American Thoracic Society (ATS) 2020 congress, the three accepted NOVELTY abstracts have now been published in the American Journal of Respiratory and Critical Care Medicine: you can read summaries of these abstracts here. These presentations will be available as part of ‘ATS 2020 Virtual’ in August, covering the following topics:

Validation of the Respiratory Symptoms Questionnaire
Frequent cough and/or mucus production across the spectrum of obstructive lung disease
A genetic analysis of ~1,900 NOVELTY patients.

19 PARTICIPATING COUNTRIES^a

~12,000 ENROLLED PATIENTS^a

84% OF PATIENTS HAVE SPIROMETRY DATA^b

You are now leaving: http://aznoveltyproject.com/

By following this link you will be leaving the NOVELTY study website.

Please note that AstraZeneca does not take responsibility for the content displayed on other websites.

Continue Return to NOVELTY study